Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  In Vitro Cellular & Developmental Biology - Animal

• Publication date

  2014-12-25

• Fields of study

  Medicine, Materials Science, Chemistry, Engineering

• Identifiers
  DOI 10.1007/s11626-014-9854-yPMID 25539863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes of bone density in pediatric patients with β-thalassemia major after allogenic hematopoietic stem cell transplantation.

  2013cited by this paper
• Autologous serum enhances cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells in the presence of transforming growth factor-β1 (TGF-β1)

  2013cited by this paper
• Comparison of the Ex Vivo Expansion of UCB-Derived CD34+ in 3D DBM/MBA Scaffolds with USSC as a Feeder Layer

  2013cited by this paper
• Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits.

  2012cited by this paper
• Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo

  2012cited by this paper
• In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells.

  2011cited by this paper
• Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.

  2011cited by this paper
• Comprehension of ECM-cell dynamics: a prerequisite for tissue regeneration.

  2010cited by this paper
• Defining Elastic Fiber Interactions by Molecular Fishing

  2009cited by this paper
• Three‐dimensional porous scaffolds at the crossroads of tissue engineering and cell‐based gene therapy

  2009cited by this paper
• Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells

  2009cited by this paper
• A tissue‐like construct of human bone marrow MSCs composite scaffold support in vivo ectopic bone formation

  2009cited by this paper
• Secondary repair of alveolar clefts using human mesenchymal stem cells.

  2009cited by this paper
• Tendon re-attachment to metal prostheses in an in vivo animal model using demineralised bone matrix.

  2009cited by this paper
• Cell-free and cell-based approaches for bone regeneration

  2009cited by this paper
• Crosslinked Three-Dimensional Demineralized Bone Matrix for the Adipose-Derived Stromal Cell Proliferation and Differentiation

  2008cited by this paper
• Human fetal bone cells associated with ceramic reinforced PLA scaffolds for tissue engineering.

  2008cited by this paper
• Expansion of hematopoietic stem/progenitor cells

  2008cited by this paper
• The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.

  2008cited by this paper
• Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering.

  2007cited by this paper
• Matrices and scaffolds for drug delivery in vascular tissue engineering.

  2007cited by this paper
• Negative regulation of TGF-β receptor/Smad signal transduction

  2007cited by this paper
• Biological Designer Self-Assembling Peptide Nanofiber Scaffolds Significantly Enhance Osteoblast Proliferation, Differentiation and 3-D Migration

  2007cited by this paper
• Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density.

  2007cited by this paper
• Stem cell niches

  2007cited by this paper
• Application of scaffold materials in tissue reconstruction in immunocompetent mammals: our experience and future requirements.

  2007cited by this paper
• Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications.

  2007cited by this paper
• Negative regulation of TGF-beta receptor/Smad signal transduction.

  2007cited by this paper
• Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.

  2007cited by this paper
• Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.

  2007cited by this paper
• Bioabsorbable scaffold for in situ bone regeneration.

  2006cited by this paper
• Stem-cell therapies for blood diseases

  2006cited by this paper
• Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro.

  2006cited by this paper
• Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin.

  2006cited by this paper
• EDB fibronectin and angiogenesis – a novel mechanistic pathway

  2005cited by this paper
• Designer self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures.

  2005cited by this paper
• A CO-CULTURE SYSTEM FOR EXPANSION NONENRICHED CORD BLOOD STEM/PROGENITOR CELLS

  2005cited by this paper
• Bone Tissue Engineering

  2005cited by this paper
• Applications of Cell Immobilisation Biotechnology

  2005cited by this paper
• In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering.

  2005cited by this paper
• Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds.

  2003cited by this paper
• Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix.

  2003cited by this paper
• Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.

  2000cited by this paper
• Development of fibrin derivatives for controlled release of heparin-binding growth factors.

  2000cited by this paper
• Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation

  1998cited by this paper
• Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand

  1997cited by this paper
• The biology and clinical uses of blood stem cells.

  1997cited by this paper
• Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics.

  1996cited by this paper
• In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum‐free culture conditions

  1994cited by this paper
• Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL‐3), IL‐6, granulocyte‐macrophage colony stimulating factor (GM‐CSF) and stem cell factor (SCF) in serum‐supplemented and serum‐free medium

  1994cited by this paper
• Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor

  1993cited by this paper
• Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

  1992cited by this paper
• Transforming growth factor-beta: a bidirectional regulator of hematopoietic cell growth.

  1992cited by this paper
• Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro

  1991cited by this paper

• Anti-Breast Cancer Effects of Free and Nanocarrier-Loaded Salinomycin and Doxorubicin

  2025cites this paper
• Doxorubicin-loaded NK exosomes enable cytotoxicity against triple-negative breast cancer spheroids

  2024cites this paper
• Distinctive Expression of Metastamirs in Breast Cancer Mesenchymal Stem Cells Isolated from Solid Tumor.

  2024cites this paper
• Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.

  2023cites this paper
• Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art

  2023cites this paper
• miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway

  2022cites this paper
• Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity

  2022cites this paper
• Enhanced Osteoinductivity of Demineralized Bone Matrix with Noggin Suppression in Polymer Matrix.

  2021cites this paper
• Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics

  2018cites this paper
• Varying miR-193b-3p Expression Patterns in Breast Cancer Cell Lines Indicates Its Potential for Cancer Management Strategies

  2018cites this paper
• Bushenhuoxue Formula Facilitates Articular Cartilage Repair and Attenuates Matrix Degradation by Activation of TGF-β Signaling Pathway

  2018cites this paper
• Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy

  2018cites this paper
• Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications

  2017cites this paper
• Demineralized Bone Matrix Scaffolds Modified by CBD-SDF-1α Promote Bone Regeneration via Recruiting Endogenous Stem Cells.

  2016cites this paper